GC Biopharma Corp - Company Profile
Powered by 
All the data and insights you need on GC Biopharma Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date GC Biopharma Corp Strategy Report
- Understand GC Biopharma Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on GC Biopharma Corp’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 28 Apr 2022 | GC Pharma to Enter into Option Agreement with Acuitas Therapeutics | Licensing Agreement |
GC Biopharma Corp
|
Acuitas Therapeutics Inc
|
| 10 Feb 2022 | Curevo Vaccine Raises USD60 Million in Series A Financing | Venture Financing |
Adjuvant Capital Inc
EnInvestment
GC Biopharma Corp
RA Capital Management LP
Janus Henderson Investors
|
Curevo Inc
|
| 27 Jan 2022 | Cyrus Therapeutics Raises USD24 Million in Series B Financing | Venture Financing |
Kolon Investment, Inc.
Mirae Asset Venture Investment Co. Ltd.
Atinum Investment Co Ltd
Time Folio Asset Management
Paratus Investment
GC Biopharma Corp
Mirae Asset Capital Co Ltd
|
Cyrus Therapeutics Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer